125 South Clark Street, Suite 750, Chicago, IL 60603
Enfusion, Inc. is a C-corporation organized and existing under the laws of the State of Delaware.
You can purchase Enfusion Inc.’s Class A common stock through a licensed securities broker.
Our stock symbol is ‘ENFN’ and the Class A common stock trades on the New York Stock Exchange.
You can view Enfusion, Inc.’s corporate governance information here.
To sign up for email alerts for Enfusion, Inc.’s press releases, presentations, and filings, please click here.
If you purchased shares through a broker, please contact your broker. If you held shares at the initial public offering in your name, our transfer agent is Computershare.
Our fiscal year ends December 31.
Our auditors for the fiscal year ending December 31, 2020 were Deloitte & Touche LLP.
Computershare.
Please visit http://ir.enfusion.com/ and click on Financial Information.
All of Enfusion’s filings, including any future Form 10-K will be available on our website here.
Please visit http://ir.enfusion.com/ and click on Company Profile.
Investor Relations, brian.murphy@icrinc.com
Enfusion, Inc. files quarterly reports with the SEC. See SEC Filings for details.
The Board of Directors of Enfusion Inc. has not yet set the date of our next annual meeting.
Yes, Enfusion, Inc.’s quarterly conference calls are webcast live and replays are available for a period of time after the announcement.
Information about our Board of Directors and their responsibilities is available here.
Our initial public offering was October 21st, 2021. The initial offering was priced at $17 per share.